- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-sensitive Prostate Cancer in Korea, Republic of
Total 768 results
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
Turning Point Therapeutics, Inc.Active, not recruitingAdvanced Solid Tumor | Metastatic Solid Tumors | MET Gene AlterationsUnited States, France, Korea, Democratic People's Republic of, Korea, Republic of, Spain
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
DendreonCompletedProstate CancerUnited States, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Georgetown UniversityNational Cancer Institute (NCI); Mayo Clinic; Emory University; Indiana University and other collaboratorsTerminatedMetastatic Colorectal Cancer | Pancreatic Adenocarcinoma | Colorectal Adenocarcinoma | Metastatic Pancreatic CancerUnited States
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKActive, not recruitingMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
SanofiRegeneron PharmaceuticalsCompletedProstatic Neoplasms | Neoplasm MetastasisUnited States, France, Canada, Brazil, Russian Federation, Ukraine, Australia, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Estonia, Singapore, Taiwan, Belgium, Czech Republic, Argentina, Denmark, Hungary, Israel, Italy, United Kingdom and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerCanada, United States
-
BioLineRx, Ltd.Merck Sharp & Dohme LLCCompletedMetastatic Pancreatic AdenocarcinomaUnited States, Israel, Korea, Republic of, Spain
-
Central European Cooperative Oncology GroupTerminatedProstate CancerMontenegro, Slovenia, Serbia, Russian Federation, Austria, Poland, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Lithuania, Romania, Slovakia, South Africa
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
DendreonCompletedMetastatic Androgen Independent Prostate CancerUnited States, Canada
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedSexual Dysfunction | Prostate Cancer | Radiation Toxicity | Psychosocial Effects of Cancer and Its TreatmentUnited States, Canada
-
Ferring PharmaceuticalsTerminatedProstate CancerUnited States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, Argentina, Italy, Mexico, Spain, United Kingdom, Netherlands, Australia, Colombia, Belgium, Austria, Denmark, Puerto Rico, France, Israel, Peru, Romania, Russian Federation, Hungary, Brazil, Germany, Czech Republic, C... and more
-
PfizerMedivation, Inc.CompletedProstate CancerAustralia, United States, Spain, France, Korea, Republic of, Germany, Austria, United Kingdom, Belgium, Hungary, Italy, Brazil, Netherlands, Poland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
PfizerTerminatedMetastatic Colorectal CancerKorea, Republic of, United States, Japan, Spain
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Turning Point Therapeutics, Inc.TerminatedNon-Small Cell Lung Cancer | NSCLC | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | ALK Gene MutationUnited States, Australia, Korea, Republic of
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
Astellas Pharma Global Development, Inc.PfizerRecruitingProstate CancerUnited States, Korea, Republic of, Japan, Belgium, Spain, Argentina, Australia, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slov... and more
-
Medical Research CouncilActive, not recruitingProstate CancerUnited Kingdom, Switzerland
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Platinum-resistant Ovarian Cancer | Locally Advanced Solid Tumor | Post Anti-PD-1 Melanoma | 2L+ Cervical Cancer | Neoadjuvant Melanoma | Neoadjuvant Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Non-Small Cell Lung Cancer | Post Anti-PD-(L)1 Small Cell...United States, Australia, Korea, Republic of
-
YM BioSciencesCIMYM BioSciencesTerminatedMetastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Canada, Cuba, Pakistan
-
Ferring PharmaceuticalsMemorial Sloan Kettering Cancer Center; Duke Clinical Research InstituteTerminatedProstate CancerUnited States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
-
PMV Pharmaceuticals, IncMerck Sharp & Dohme LLCRecruitingBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Solid Tumor | Other Cancer | Advanced Malignant Neoplasm | Locally AdvancedUnited States, Spain, Korea, Republic of, Singapore, Australia, France, Germany, Italy, United Kingdom
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate Carcinoma | Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage IV Renal... and other conditionsUnited States, Puerto Rico
-
GI Innovation, Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Sarcoma | Renal Cell Carcinoma | Cervical Cancer | Urinary Bladder Cancer | Vulvar Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Merkel Cell Carcinoma | Vaginal Cancer | Microsatellite Stable...Korea, Republic of, United States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic